2-31200622-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_001145122.2(CAPN14):c.555C>T(p.Leu185Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000565 in 1,543,220 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0027 ( 2 hom., cov: 32)
Exomes 𝑓: 0.00033 ( 2 hom. )
Consequence
CAPN14
NM_001145122.2 synonymous
NM_001145122.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.486
Publications
1 publications found
Genes affected
CAPN14 (HGNC:16664): (calpain 14) Calpains are a family of cytosolic calcium-activated cysteine proteases involved in a variety of cellular processes including apoptosis, cell division, modulation of integrin-cytoskeletal interactions, and synaptic plasticity (Dear et al., 2000 [PubMed 10964513]). CAPN14 belongs to the calpain large subunit family.[supplied by OMIM, Mar 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 2-31200622-G-A is Benign according to our data. Variant chr2-31200622-G-A is described in ClinVar as Benign. ClinVar VariationId is 780816.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.486 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 2 AR gene
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CAPN14 | ENST00000403897.4 | c.555C>T | p.Leu185Leu | synonymous_variant | Exon 6 of 22 | 2 | NM_001145122.2 | ENSP00000385247.3 | ||
| CAPN14 | ENST00000398824.6 | n.418C>T | non_coding_transcript_exon_variant | Exon 6 of 22 | 2 | ENSP00000381805.2 |
Frequencies
GnomAD3 genomes AF: 0.00273 AC: 416AN: 152194Hom.: 2 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
416
AN:
152194
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000735 AC: 108AN: 146896 AF XY: 0.000644 show subpopulations
GnomAD2 exomes
AF:
AC:
108
AN:
146896
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000326 AC: 454AN: 1390908Hom.: 2 Cov.: 31 AF XY: 0.000318 AC XY: 218AN XY: 685666 show subpopulations
GnomAD4 exome
AF:
AC:
454
AN:
1390908
Hom.:
Cov.:
31
AF XY:
AC XY:
218
AN XY:
685666
show subpopulations
African (AFR)
AF:
AC:
308
AN:
31108
American (AMR)
AF:
AC:
18
AN:
33330
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
24632
East Asian (EAS)
AF:
AC:
0
AN:
35626
South Asian (SAS)
AF:
AC:
4
AN:
77506
European-Finnish (FIN)
AF:
AC:
0
AN:
49200
Middle Eastern (MID)
AF:
AC:
12
AN:
5644
European-Non Finnish (NFE)
AF:
AC:
66
AN:
1076262
Other (OTH)
AF:
AC:
46
AN:
57600
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
21
42
63
84
105
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00274 AC: 418AN: 152312Hom.: 2 Cov.: 32 AF XY: 0.00246 AC XY: 183AN XY: 74488 show subpopulations
GnomAD4 genome
AF:
AC:
418
AN:
152312
Hom.:
Cov.:
32
AF XY:
AC XY:
183
AN XY:
74488
show subpopulations
African (AFR)
AF:
AC:
386
AN:
41566
American (AMR)
AF:
AC:
21
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5178
South Asian (SAS)
AF:
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
AC:
6
AN:
68020
Other (OTH)
AF:
AC:
4
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
21
43
64
86
107
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Apr 20, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.